The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction
Abstract
Background Recent data suggest that triglyceride-rich lipoproteins may play a role in atherogenesis. However, whether triglycerides, as a marker for these lipoproteins, represent an independent risk factor for coronary heart disease remains unclear, despite extensive research. Several methodological issues have limited the interpretability of the existing data. Methods and Results We examined the interrelationships of fasting triglycerides, other lipid parameters, and nonlipid risk factors with risk of myocardial infarction among 340 cases and an equal number of age-, sex-, and community-matched control subjects. Cases were men or women of <76 years of age with no prior history of coronary disease who were discharged from one of six Boston area hospitals with the diagnosis of a confirmed myocardial infarction. In crude analyses, we observed a significant association of elevated fasting triglycerides with risk of myocardial infarction (relative risk [RR] in the highest compared with the lowest quartile=6.8; 95% confidence interval [CI]=3.8 to 12.1; P for trend <.001). Results were not materially altered after control for nonlipid coronary risk factors. As expected, the relationship was attenuated after adjustment for HDL but remained statistically significant (RR in the highest quartile=2.7; 95% confidence interval [CI]=1.4 to 5.5; P for trend=.016). Furthermore, the ratio of triglycerides to HDL was a strong predictor of myocardial infarction (RR in the highest compared with the lowest quartile=16.0; 95% CI=7.7 to 33.1; P for trend <.001). Conclusions Our data indicate that fasting triglycerides, as a marker for triglyceride-rich lipoproteins, may provide valuable information about the atherogenic potential of the lipoprotein profile, particularly when considered in context of HDL levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reproducibility and validity of a semiquantitative food frequency questionnaire
WILLETT, W. C., SAMPSON, L., STAMPFER, M. J., ROSNER, B., BAIN, C., WITSCHI, J., HENNEKENS, C. H., & SPEIZER, F. E. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114086 · Cited by 4,274
Self-citationLow-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
Self-citationGaziano, J. M., Buring, J. E., Breslow, J. L., Goldhaber, S. Z., Rosner, B., VanDenburgh, M., Willett, W., & Hennekens, C. H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292501 · Cited by 1,024
Self-citationLipid Research Clinics Program
Renfrew, R. A. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350180015009 · Cited by 829
THE RELATIONSHIP OF PSYCHOSOCIAL FACTORS TO CORONARY HEART DISEASE IN THE FRAMINGHAM STUDY
HAYNES, S. G., LEVINE, S., SCOTCH, N., FEINLEIB, M., & KANNEL, W. B. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112556 · Cited by 800
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. A. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Hulley, S. B., Rosenman, R. H., Bawol, R. D., & Brand, R. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006193022503 · Cited by 702
The triglyceride issue: A view from Framingham
Castelli, W. P. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90296-6 · Cited by 658
Cited by
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Self-citationCarr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
Dobiás̆ová, M., & Frohlich, J. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00263-6 · Cited by 1,438
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Second Joint Task Force of European (1998) · European Heart Journal · doi:10.1053/euhj.1998.1243 · Cited by 1,131
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M., Saraiva, J., Chacra, A., Bianco, H., Afiune Neto, A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 633
Miller, M., Cannon, C. P., Murphy, S. A., Qin, J., Ray, K. K., & Braunwald, E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.038 · Cited by 610
The metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579
“High levels of plasma triglycerides have been associated with an increase in insulin resistance (29), which has also been reported as a risk factor for cardiovascular disease (30).”
BackgroundO’Keefe, J. H., & Bell, D. S. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.107 · Cited by 538
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease
Reaven, G. (2002) · Circulation · doi:10.1161/01.cir.0000019884.36724.d9 · Cited by 494
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427
Onat, A., Can, G., Kaya, H., & Hergenç, G. (2010) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2010.02.005 · Cited by 421
Dobiášová, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.033175 · Cited by 419
High Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease
Luz, P. L. D., Favarato, D., Junior, J. R. F.-N., Lemos, P., & Chagas, A. C. P. (2008) · Clinics · doi:10.1590/s1807-59322008000400003 · Cited by 385
Wakabayashi, I., & Daimon, T. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.042 · Cited by 377
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Circulation · doi:10.1161/01.cir.0000145615.33955.83 · Cited by 358
The Triglyceride-to-HDL Cholesterol Ratio
Giannini, C., Santoro, N., Caprio, S., Kim, G., Lartaud, D., Shaw, M., Pierpont, B., & Weiss, R. (2011) · Diabetes Care · doi:10.2337/dc10-2234 · Cited by 360
Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Dokras, A., Bochner, M., Hollinrake, E., Markham, S., VanVoorhis, B., & Jagasia, D. H. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000167408.30893.6b · Cited by 353
Risk factors for coronary heart disease: implications of gender
Roeters van Lennep, J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00388-1 · Cited by 300
Brinkworth, G. D., Noakes, M., Buckley, J. D., Keogh, J. B., & Clifton, P. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27326 · Cited by 284
“Elevated triglyceride concentrations have also been identified as an independent CVD risk factor (34), and the triglyceride:HDL cholesterol ratio is considered a strong predictor of future cardiac events (35) and is a surrogate measure of insulin resistance (36).”
Backgroundn−3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik
Dewailly, E., Blanchet, C., Lemieux, S., Sauvé, L., Gingras, S., Ayotte, P., & Holub, B. J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.464 · Cited by 276
Hoeger, K., Davidson, K., Kochman, L., Cherry, T., Kopin, L., & Guzick, D. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0461 · Cited by 256
The LDL to HDL Cholesterol Ratio as a Valuable Tool to Evaluate Coronary Heart Disease Risk
Fernandez, M. L., & Webb, D. (2008) · Journal of the American College of Nutrition · doi:10.1080/07315724.2008.10719668 · Cited by 255
Miller, M., Seidler, A., Moalemi, A., & Pearson, T. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00083-7 · Cited by 193
“A recent casecontrol study (47) supports the meta-analysis by Hokanson and Austin (48) that TG independently predicts initial CAD events even after adjustment for HDL-C.”
ResultJenkins, D. J., Kendall, C. W., Faulkner, D. A., Nguyen, T., Kemp, T., Marchie, A., Wong, J. M., de Souza, R., Emam, A., Vidgen, E., et al. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.83.3.582 · Cited by 184
Hanak, V., Munoz, J., Teague, J., Stanley, A., & Bittner, V. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.069 · Cited by 167
Epidemiologic aspects of lipid abnormalities
Criqui, M. H., & Golomb, B. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00212-5 · Cited by 158
Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies
Colantonio, L. D., Bittner, V., Reynolds, K., Levitan, E. B., Rosenson, R. S., Banach, M., Kent, S. T., Derose, S. F., Zhou, H., Safford, M. M., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.011646 · Cited by 105
Metabolic abnormalities: triglyceride and low-density lipoprotein
Krauss, R. M., & Siri, P. W. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.016 · Cited by 102
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis
Clee, S. M., Bissada, N., Miao, F., Miao, L., Marais, A. D., Henderson, H. E., Steures, P., McManus, J., McManus, B., LeBoeuf, R. C., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32399-3 · Cited by 101
Docosahexaenoic acid (DHA) and cardiovascular disease risk factors
Holub, B. J. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.016 · Cited by 100
Geppert, J., Kraft, V., Demmelmair, H., & Koletzko, B. (2006) · British Journal of Nutrition · doi:10.1079/bjn20051720 · Cited by 96
Serum Lipid Survey and Its Recent Trend in the General Japanese Population in 2000
Arai, H., Yamamoto, A., Matsuzawa, Y., Saito, Y., Yamada, N., Oikawa, S., Mabuchi, H., Teramoto, T., Sasaki, J., Nakaya, N., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.98 · Cited by 94
LDL-Apheresis: Technical and Clinical Aspects
Bambauer, R., Bambauer, C., Lehmann, B., Latza, R., & Schiel, R. (2012) · The Scientific World Journal · doi:10.1100/2012/314283 · Cited by 91
Murad, M. H., Hazem, A., Coto-Yglesias, F., Dzyubak, S., Gupta, S., Bancos, I., Lane, M. A., Erwin, P. J., Berglund, L., Elraiyah, T., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-2 · Cited by 87
Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants
Saito, T., Oikawa, S., Sato, H., & Sasaki, J. (1999) · Nephron · doi:10.1159/000045511 · Cited by 46
Enhancement of preheparin serum lipoprotein lipase mass by bezafbirate administration
Totsuka, M., Miyashita, Y., Ito, Y., Watanabe, H., Murano, T., & Shirai, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00394-4 · Cited by 43
Shimomura, T., & Wakabayashi, I. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-104 · Cited by 30
Exercise, postprandial triacylglyceridemia, and cardiovascular disease risk.
Graham, T. E. (2004) · Canadian Journal of Applied Physiology · doi:10.1139/h04-051 · Cited by 28
Kasprzak, Z., & Pilaczyńska-Szcześniak, Ł. (2014) · Journal of Human Kinetics · doi:10.2478/hukin-2014-0034 · Cited by 26
Metadata
- Authors
- Gaziano, J. M., Hennekens, C. H., O’Donnell, C. J., Breslow, J. L., & Buring, J. E.
- Venue
- Circulation
- Published
- 1997-10-21
- Volume
- 96
- Issue
- 8
- Pages
- 2520-2525
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1979352055
- Cited by
- 609
- References
- 31
- FWCI
- 14.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.